Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 55154-4346

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 55154-4346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 (Table 5)

This is a table presenting the effects of different doses of oral Pantoprazole on intragastric pH over a 24-hour period. The median pH values were measured on the seventh day, and the doses tested were 20mg, 40mg, and 80mg. The three different times of the day, including 8am-8am, 8am-10pm (daytime), and 10pm-8am (nighttime) were used to measure the pH values. The asterisk denotes significant differences from placebo, while the number "1" denotes significant differences from the 20mg dose.*

FDA Label Image

8 (Table 8)

This is a table showing the healing rates for erosive esophagitis for patients taking different dosages of pantoprazole and a placebo. The study had 68 participants and lasted 8 weeks. The results show that pantoprazole had a significantly higher healing rate compared to the placebo group. The healing rates were also higher for the higher dosages of pantoprazole.*

FDA Label Image

9 (Table 9)

This is a table showing the healing rates of erosive esophagitis after treatment with Pantoprazole and Nizatidine over a period of 8 weeks. The table indicates that Pantoprazole has a significantly higher healing rate compared to Nizatidine. The dosage and frequency of administration are also shown in the table.*

FDA Label Image

Bag Label (Image 01)

This is a description of Pantoprazole Sodium Delayed-Release Tablets, USP 20 mg, consisting of 10 unit dose tablets, each of which is equivalent to 20 mg pantoprazole. The package insert provides the usual dosage, prescribing recommendations, and storage instructions. The tablet must not be crushed, chewed, or split before administration. The unit dose package is not child-resistant and is only intended for institutional use. It is essential to keep this and all medications out of the children's reach, and dispensed for outpatient usage, using child-resistant containers. It also gives the manufacturer's name and product details.*

FDA Label Image

Chemical Structure (Pantoprazole Sodium Delayed Release Tablets 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.